Trial Profile
A Randomized Prospective Multicenter Trial to Compare Vascular Healing and Vasodilation at 3 Months After Deployment of PRO-Kinetic Drug-eluting Stent and Endeavor Resolute Zotarolimus-eluting Stent in Patients With Acute Coronary Syndromes by Means of Optical Coherence Tomography and Coronary Flow Reserve
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Zotarolimus (Primary)
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- Acronyms HAT-TRICK-OCT
- 25 Nov 2015 New trial record